Philip Comp to Thromboembolism
This is a "connection" page, showing publications Philip Comp has written about Thromboembolism.
Connection Strength
0.815
-
Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery. Pharmacotherapy. 2003 Jun; 23(6):772-87.
Score: 0.215
-
Treatment and management of acute venous thromboembolic disease. Thromb Res. 2003; 111(1-2):3-8.
Score: 0.209
-
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am. 2001 Mar; 83(3):336-45.
Score: 0.184
-
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61.
Score: 0.072
-
Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8.
Score: 0.062
-
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003 Oct 30; 349(18):1703-12.
Score: 0.055
-
The regulation of hemostasis: the protein C system. N Engl J Med. 1986 May 15; 314(20):1298-304.
Score: 0.017